California’s CalRx Generic Insulin Rollout Faces Slow Start at Pharmacies
California’s state-backed generic drug initiative, CalRx, faces a slow start at retail pharmacies despite offering long-acting insulin glargine pens for a recommended price of $11 each. Governor Gavin Newsom introduced ... Read More